July 2, 2018: UAS Labs Announces Licensing Agreement with AceBiome
To Manufacture and Commercialize Probiotic Strain for Weight Management, BNR17™
UAS Labs (Wausau, Wisconsin, USA) is excited to announce their licensing agreement with AceBiome (Gyeonggi-do, South Korea), a recent spin-off of the parent biotechnology company Bioneer (Daejeon, South Korea). This agreement includes the manufacturing and commercialization of patented probiotic, Lactobacillus gasseri BNR17™.
Lactobacillus gasseri BNR17™ is a weight management probiotic and the flagship product of AceBiome. This individual strain has been put through extensive pre-clinical analysis and it is the subject of three published human clinical trials. BNR17™ is approved by the Korean FDA (MFDS) as a functional ingredient used to help to reduce body fat.
Kevin Mehring, President and CEO of UAS Labs, stated “We are thrilled to formalize this partnership with AceBiome! UAS is a company dedicated to pioneering new, innovative health categories as shown with our successful launch of the patented LRC™ probiotic for maintaining heart health”. He continued “We recognized early on the strength of the Lactobacillus gasseri BNR17™ strain and the impressive clinical work AceBiome has completed around weight management and IBS. This strain delivers in meeting a growing consumer need while also leading in terms of the latest probiotic clinical research in the area. Our team of experts are eager to continue the development and promotion of this promising strain”.
Myeong Hee Kim, Founder and CEO of AceBiome, shared “We are very pleased to partner with UAS Labs in our mission to deliver the weight management benefits of BNR17™ to more people in North America and other countries.” She stated, “UAS Labs was selected as the trusted manufacturer of BNR17™ based on their commitment to producing the highest quality, probiotic-based solutions for over 35 years. In addition, their enthusiasm and entrepreneurship are well suited to make this new product an industry-leading weight management probiotic. BNR17™ will be manufactured in UAS Labs’ state-of-the-art fermentation facility located in the state of Wisconsin, USA”.
UAS Labs has always focused on beneficial bacteria that show superior growth, stability and nutritional potential and BNR17™ is no exception. UAS is proud to be the trusted manufacturer of the AceBiome strain of Lactobacillus gasseri and honored to hold various licensing rights worldwide to promote this first-rate weight management probiotic solution.
About UAS Laboratories
UAS Laboratories LLC has delivered the highest quality, science-backed probiotics to the marketplace since 1979. Strictly dedicated to probiotic manufacturing, UAS is committed to designing innovative and effective formulations that strive to enhance wellness and quality of life.
AceBiome is a start-up probiotic company spun off from Bioneer. They are known in the probiotic industry for their novel strain, Lactobacillus gasseri BNR17™, a product with 18 years of research. AceBiome is dedicated to expanding the consumer base of beneficial probiotics by partnering with like-minded industry leaders. Through these partnerships, AceBiome will deliver health benefits to people around the globe.
Bioneer (064550.KQ) is a South Korea-based biotechnology company which has been offering life science products to the global space since 1992. The company has a broad range of molecular diagnostic solutions and the platform technologies in RNAi-based therapeutics carrying a few pre-clinical programs in pipeline. Bioneer (064550.KQ) is a public company being traded on KOSDAQ, a South Korea stock exchange market.